Global S&T Development Trend Analysis Platform of Resources and Environment
Public encouraged to register for COVID-19 vaccine trials as 100,000 already sign-up | |
admin | |
2020-08-17 | |
发布年 | 2020 |
语种 | 英语 |
国家 | 英国 |
领域 | 气候变化 ; 资源环境 |
正文(英文) |
Press release
Public encouraged to register for COVID-19 vaccine trials as 100,000 already sign-upOver 100,000 people have volunteered to take part in COVID-19 vaccine trials, helping to speed up efforts to discover a safe and effective vaccine. ![]()
Over 100,000 people have volunteered to take part in COVID-19 vaccine trials, helping to speed up efforts to discover a safe and effective vaccine. The government is today (Monday 17 August) encouraging more people to join the thousands of volunteers and sign up to the NHS COVID-19 Vaccine Research Registry to help the NHS in the fight against coronavirus and ensure potential candidates work for everyone. To enable large-scale vaccine studies to take place across the UK, the aim is to get as many people as possible signed up to the Registry by October. Researchers particularly welcome people from all parts of society, especially those who are more likely to benefit from a vaccine, including the over 65s, frontline health and social care workers, and those from Black, Asian and Minority Ethnic backgrounds. Clinical studies with a diverse pool of volunteers will help scientists and researchers better understand the effectiveness of each vaccine candidate and will considerably speed up efforts to discover a safe and workable vaccine. Business Secretary Alok Sharma said:
Chair of the government’s Vaccines Taskforce Kate Bingham said:
Consultant Respiratory Physician and Director of the National Institute for Health Research (NIHR) PRC, Bradford, Dinesh Saralaya said:
18-year-old Marium Zumeer from Bradford, who was hospitalised after contracting COVID-19, has first-hand experience of the benefits of taking part in clinical trials. During her time in intensive care, she was offered the opportunity to take part in the national RECOVERY trial, which is testing a range of potential treatments for COVID-19. This includes the drug dexamethasone, which was found to be the first drug to be effective when treating those who are critically ill with the virus. RECOVERY trial volunteer Marium Zumeer said:
Chief Medical Officer Professor Chris Whitty said:
A number of trials in the UK are expected to begin this autumn, working with the NHS, research institutions and businesses, helping to develop and manufacture the vaccines. Launched on 20 July, the NHS COVID-19 Vaccine Research Registry is an online service allowing members of the public to register their interest in COVID-19 vaccine studies and be contacted to participate in future clinical trials. Vaccines are tested in stages to ensure they are safe and effective. Volunteers who are contacted to take part in trials will be given information about what stage a particular vaccine is at and details of how it has already been tested. They will be able to consider this when deciding to take part and people can withdraw from the registry at any point. The Registry has been developed by the government, in partnership with the NIHR, NHS Digital, the Scottish and Welsh governments and the Northern Ireland Executive. Notes to editorsAbout the Vaccine TaskforceThe Vaccine Taskforce (VTF) was set up under the Department for Business, Energy and Industrial Strategy (BEIS) in May 2020, to ensure that the UK population has access to clinically effective and safe vaccines as soon as possible, while working with partners to support international access to successful vaccines. This is to place the UK at the forefront of global vaccine research, development, manufacture and distribution. The Vaccine Taskforce comprises a dedicated team of private sector industry professionals and officials from across government who are working at speed to build a portfolio of promising vaccine candidates that can end the global pandemic. It is chaired by biotech and life sciences expert Kate Bingham, who was appointed by the Prime Minister Boris Johnson. The Vaccine Taskforce’s approach to securing access to vaccines is through:
About the NIHRThe National Institute for Health Research (NIHR) is the nation’s largest funder of health and care research. The NIHR:
The NIHR was established in 2006 to improve the health and wealth of the nation through research and is funded by the Department of Health and Social Care. In addition to its national role, the NIHR supports applied health research for the direct and primary benefit of people in low- and middle-income countries, using UK aid from the UK government.
Published 17 August 2020
|
URL | 查看原文 |
来源平台 | Department for Business, Energy & Industrial Strategy |
文献类型 | 新闻 |
条目标识符 | http://119.78.100.173/C666/handle/2XK7JSWQ/287292 |
专题 | 气候变化 资源环境科学 |
推荐引用方式 GB/T 7714 | admin. Public encouraged to register for COVID-19 vaccine trials as 100,000 already sign-up. 2020. |
条目包含的文件 | 条目无相关文件。 |
个性服务 |
推荐该条目 |
保存到收藏夹 |
查看访问统计 |
导出为Endnote文件 |
谷歌学术 |
谷歌学术中相似的文章 |
[admin]的文章 |
百度学术 |
百度学术中相似的文章 |
[admin]的文章 |
必应学术 |
必应学术中相似的文章 |
[admin]的文章 |
相关权益政策 |
暂无数据 |
收藏/分享 |
除非特别说明,本系统中所有内容都受版权保护,并保留所有权利。
修改评论